Numinus will ring the TSX opening bell to celebrate this milestone
VANCOUVER, BC, Dec. 14, 2021 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce that it has received final approval from the Toronto Stock Exchange (“TSX”) to graduate its listing to the TSX from the TSX-Venture Exchange (“TSXV”). Numinus’ common shares will commence trading on the TSX under the symbol “NUMI” at market open on Thursday, December 16, 2021. Similarly, the Company’s listed warrants will commence trading on the TSX under the symbols “NUMI.WT”, “NUMI.WT.B” and “NUMI.WT.C” on the same day.
No actions are required by Numinus shareholders. There will be no change to the shares, warrants or Company share structure as a result of this listing graduation. The TSX and TSXV have published bulletins announcing the change to financial institutions.
TSX Opening Bell Ringing
Numinus will celebrate this milestone by ringing the opening bell of the TSX on Thursday, December 16, 2021. Numinus Founder and CEO, Payton Nyquvest, will be joined by members of Numinus’ senior management team at the event.
Numinus helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic production, research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect” and “intend” and statements that an event “may”, “will”, “should”, “could” or “might” occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management’s estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Numinus Wellness Inc.
For further information: Investor Contact: Jamie Kokoska, Vice President, Investor Relations, email@example.com; Media Contact: May Lee, Communications Manager, firstname.lastname@example.org